Skip to content

Isopropyl alcohol inhalation as first-line treatment for nausea in the Dutch emergency department.

Aromatherapy with isopropyl alcohol as first-line therapy for nausea in the Dutch Emergency Department: an implementation study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29124
Enrollment
160
Registered
2018-05-23
Start date
2018-04-24
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The experience of nausea in the Emergency Department. Keywords: Isopropyl alcohol IPA Nausea Emergency Department

Interventions

This is an implementation trail aiming to study the practical aspects of the IPA as first-line therapy. In the first phase the current treatment with conventional anti-emetics will be studied. In the

Sponsors

Westfriesgasthuis Hoorn
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients > 18 years who react positively to the following question: “Are you nauseous or do you feel like throwing up or have to vomit?”

Exclusion criteria

Exclusion criteria: - patients allergic to IPA - patients with impaired ability to inhale nasally (severely nasally congested patients, facial trauma, congenital deformations, etc) - patients that cannot be properly instructed (e.g. decreased level of consciousness) - pregnant patients - patients <18 years

Design outcomes

Primary

MeasureTime frame
Time to treatment: the time in minutes between the detection of nausea by ED staff and the administration of the symptomatic treatment for nausea.

Secondary

MeasureTime frame
- Percentage of nauseous patients that are symptomatically treated - Percentage of patients receiving conventional anti-emetics - Cost of symptomatic treatment of nausea - ED staff experiences with IPA inhalation therapy with use of questionaire

Contacts

Public ContactP.B. Veldhuis
p.b.veldhuis@westfriesgasthuis.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)